Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PROgnostic Testing to Enhance Clinical Triage of Preeclampsia in Africa (PROTECT-Africa): Biomarker Validation for Timely Intervention in Hypertensive Disorders of Pregnancy

NCT07810439 is registered in ClinicalTrials.gov with Africa Clinical Research Network (ACRN) as lead sponsor.

NCT NCT07810439
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07810439 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PROgnostic Testing to Enhance Clinical Triage of Preeclampsia in Africa (PROTECT-Africa): Biomarker Validation for Timely Intervention in Hypertensive Disorders of Pregnancy
Lead sponsor
Africa Clinical Research Network (ACRN)
Phase
Observational
Overall status
Recruiting
Start date
February 5, 2026
Completion date
February 28, 2027
Enrollment
1,106 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

eclampsia, fetal growth retardation, hellp syndrome, hypertension, pregnancy-induced, pre-eclampsia